World's Best Scientists 2026 revealed!
Award Badge
Medicine
Spain
2023

D-Index & Metrics

Medicine

D-Index
96
Citations
42741
World Ranking
9531
National Ranking
138

Carlos Macaya publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Carlos Macaya sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 860 publications — 90th percentile

90% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Carlos Macaya D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Carlos Macaya sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 96 D-Index — 53rd percentile

53% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2023 - Research.com Medicine in Spain Leader Award

Overview

Carlos Macaya is affiliated with the Complutense University of Madrid in Spain. Their primary field of study is Medicine, with a significant focus on Cardiology and Cardiovascular Medicine, Infectious Diseases, Surgery, Neurology, and Pulmonary and Respiratory Medicine.

The scientist's research topics include:

  • COVID-19 Clinical Research Studies
  • Long-Term Effects of COVID-19
  • Cardiac Valve Diseases and Treatments
  • Coronary Interventions and Diagnostics
  • COVID-19 and healthcare impacts
  • Infective Endocarditis Diagnosis and Management
  • Cardiac Imaging and Diagnostics

Frequent co-authors collaborating with Carlos Macaya are:

  • Antonio Fernández-Ortíz
  • Iván J. Núñez-Gil
  • Vicente Estrada
  • Víctor Manuel Becerra-Muñoz
  • Pilar Jiménez-Quevedo

Key publication venues where Carlos Macaya has contributed include:

  • European Heart Journal
  • European Journal of Clinical Investigation
  • EuroIntervention
  • Revista Española de Cardiología (English Edition)
  • REC interventional cardiology (English Edition)

Selected recent papers cover various aspects of COVID-19 and cardiovascular medicine. These include:

  • Clinical profile and predictors of in-hospital mortality among older patients hospitalised for COVID-19, 2020, Age and Ageing
  • Impact of renal function on admission in COVID-19 patients: an analysis of the international HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID 19) Registry, 2020, Journal of Nephrology
  • Prognostic Impact of Hyponatremia and Hypernatremia in COVID-19 Pneumonia. A HOPE-COVID-19 (Health Outcome Predictive Evaluation for COVID-19) Registry Analysis, 2020, Frontiers in Endocrinology
  • Antiplatelet therapy and outcome in COVID-19: the Health Outcome Predictive Evaluation Registry, 2021, Heart
  • Non-invasive ventilation for SARS-CoV-2 acute respiratory failure: a subanalysis from the HOPE COVID-19 registry, 2021, Emergency Medicine Journal

Best Publications

  • A Comparison of Balloon-Expandable-Stent Implantation with Balloon Angioplasty in Patients with Coronary Artery Disease

    P. W. Serruys;P. de Jaegere;F. Kiemeneij;C. Macaya

  • Variability in Individual Responsiveness to Clopidogrel: Clinical Implications, Management, and Future Perspectives

    Dominick J. Angiolillo;Antonio Fernandez-Ortiz;Esther Bernardo;Fernando Alfonso

  • Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial.

    Patrick W. J. C. Serruys;Pim de Feyter;Carlos Macaya;Norbert Kokott

  • Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II)

    Patrick W. Serruys;Ben Van Hout;Hans Bonnier;Victor Legrand

  • Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial.

    Shamir R. Mehta;Jean-François Tanguay;John W. Eikelboom;Sanjit S. Jolly

  • Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies.

    Raúl Moreno;Cristina Fernández;Rosana Hernández;Fernando Alfonso

  • Comparison of Zotarolimus-Eluting and Everolimus-Eluting Coronary Stents

    Patrick W Serruys;Sigmund Silber;Scot Garg;Robert Jan van Geuns

  • Platelet Function Profiles in Patients With Type 2 Diabetes and Coronary Artery Disease on Combined Aspirin and Clopidogrel Treatment

    Dominick J. Angiolillo;Antonio Fernandez-Ortiz;Esther Bernardo;Celia Ramírez

  • Randomized Evaluation of Anticoagulation Versus Antiplatelet Therapy After Coronary Stent Implantation in High-Risk Patients The Multicenter Aspirin and Ticlopidine Trial after Intracoronary Stenting (MATTIS)

    Philip Urban;Carlos Macaya;Hans-Jürgen Rupprecht;Ferdinand Kiemeneij

  • Randomized Comparison of Sirolimus-Eluting Stent Versus Standard Stent for Percutaneous Coronary Revascularization in Diabetic Patients The Diabetes and Sirolimus-Eluting Stent (DIABETES) Trial

    Manel Sabaté;Pilar Jiménez-Quevedo;Dominick J. Angiolillo;Joan Antoni Gómez-Hospital

  • Effect of Early Metoprolol on Infarct Size in ST-Segment–Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention The Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) Trial

    Borja Ibanez;Carlos Macaya;Vicente Sánchez-Brunete;Gonzalo Pizarro

  • Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention.

    Gilles Montalescot;Harvey D. White;Richard Gallo;Marc Cohen

  • Impact of Platelet Reactivity on Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease

    Dominick J. Angiolillo;Esther Bernardo;Manel Sabaté;Pilar Jimenez-Quevedo

  • High clopidogrel loading dose during coronary stenting: effects on drug response and interindividual variability

    Dominick J. Angiolillo;Antonio Fernández-Ortiz;Esther Bernardo;Celia Ramírez

  • Insulin Therapy Is Associated With Platelet Dysfunction in Patients With Type 2 Diabetes Mellitus on Dual Oral Antiplatelet Treatment

    Dominick J. Angiolillo;Esther Bernardo;Celia Ramírez;Marco A. Costa

  • Diagnosis of spontaneous coronary artery dissection by optical coherence tomography

    Fernando Alfonso;Manuel Paulo;Nieves Gonzalo;Jaime Dutary

  • A randomized placebo-controlled trial of fluvastatin for prevention of restenosis after successful coronary balloon angioplasty; final results of the fluvastatin angiographic restenosis (FLARE) trial.

    P W Serruys;D P Foley;G Jackson;H Bonnier

  • Long-Term Clinical Outcomes After Unprotected Left Main Trunk Percutaneous Revascularization in 279 Patients

    Walter A. Tan;Hideo Tamai;Seung Jung Park;H. W Thijs Plokker

  • Spontaneous Coronary Artery Dissection: Long-Term Follow-Up of a Large Series of Patients Prospectively Managed With a “Conservative” Therapeutic Strategy

    Fernando Alfonso;Manuel Paulo;Vera Lennie;Jaime Dutary

  • A Prospective Randomized Trial of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis of Drug-Eluting Stents: The RIBS IV Randomized Clinical Trial.

    Fernando Alfonso;María Jose Pérez-Vizcayno;Alberto Cárdenas;Bruno García del Blanco

Frequent Co-Authors

Fernando Alfonso
Fernando Alfonso Hospital Universitario de La Princesa
Javier Escaned
Javier Escaned Hospital Clínico San Carlos
Manel Sabaté
Manel Sabaté University of Barcelona
José Luis Zamorano
José Luis Zamorano Hospital Ramon y Cajal
Dominick J. Angiolillo
Dominick J. Angiolillo University of Florida
Patrick W. Serruys
Patrick W. Serruys University of Galway
Borja Ibanez
Borja Ibanez Spanish National Centre for Cardiovascular Research
Eulogio García
Eulogio García Hospital Clínico San Carlos
Josep Rodés-Cabau
Josep Rodés-Cabau Université Laval
Antonio Colombo
Antonio Colombo Humanitas Clinical and Research Center IRCCS

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative healthcare degrees can open doors to numerous high-demand careers in medicine and health services. Online programs offer flexibility, often with lower tuition costs and the ability to balance studies with personal commitments.

Those looking to move into leadership can consider the cheapest online mha programs to gain essential skills for healthcare administration roles. If advanced clinical practice is your goal, cheap online dnp programs provide a pathway to become a Doctor of Nursing Practice.

Aspiring pharmacists can pursue an online pharmacist degree, which delivers the professional training needed for pharmacy licensure in a flexible format. Alternatively, careers in healthcare data and patient information management are growing rapidly, with programs like a health information management degree online preparing students for these specialized roles.

With the increasing availability of accredited online degrees, future medical professionals and administrators now have more accessible and affordable options to further their education and advance their careers.

Best Scientists Citing Carlos Macaya

Trending Scientists

Recently Published Articles